VC Funding Is Back. Is Venture Capital?

Headline totals show a sharp recovery in deployed capital. Global VC investment rose from $391.9 billion in 2024 to more than $500 billion in 2025. In the first half of 2026 alone, it reached $560.4 billion—more than in any full year except 2021.[1]

Those totals conceal how narrowly capital is distributed across companies, stages and funds.

Venture capital is deploying more money through a narrower financing system. Total investment has recovered while access for the typical startup has deteriorated. Capital deployed measures transaction volume; capital availability measures the probability that an ordinary company can finance itself. A small number of exceptional companies now raise unprecedented sums while the financing funnel for the rest remains constrained.

The venture market now has a barbell structure.

Dollars and deals are moving in opposite directions

Global venture investment rose from $391.9 billion in 2024 to more than $500 billion in 2025 as deal activity weakened. In Q4 2025, $138.1 billion was invested across 7,981 deals. By Q2 2026, quarterly investment had reached $227.4 billion across 8,440 deals, with the ten largest transactions accounting for $105 billion—nearly half the total.[2]

Q4 2025

$138.1bn

Q2 2026

$227.4bn

Q2 2026: top 10 deals = $105bn, roughly 46% of the quarterly total.

Source: [2]

The market is funding fewer companies with larger cheques.

The United States shows the concentration most clearly. US startups raised more than $400 billion in H1 2026, already exceeding every previous full-year total. AI companies and rounds of $100 million or more absorbed the overwhelming majority of that capital. A narrow group of companies capable of deploying extraordinary sums now drives the aggregate recovery.[3]

A handful of companies can now move global venture totals by tens of billions of dollars. The aggregate is increasingly a statistic about the upper tail.

AI drives this divergence. In Q1 2026, more than 60 cents of every venture dollar invested through Carta went to AI companies; within SaaS, the share was 83%. KPMG and NVCA likewise report that the largest financings and the overwhelming majority of US capital were concentrated in AI and mega-rounds. The market now operates on two tracks: exceptional AI infrastructure, model and platform companies can absorb tens of billions of dollars, while almost everyone else competes within a constrained pool.[4]

All venture capital

AI 60%Other 40%

SaaS capital

AI 83%Other 17%

Source: [4]

The financing funnel is narrowing

Stage progression reveals the contraction. Carta recorded fewer seed and Series A investments in 2024 as total capital rose. For companies that raised a Series B in 2025, the median interval from Series A stretched to 2.75 years. The next financing gate now takes longer to clear.[5]

The seed-to-Series-A conversion rate has fallen sharply on a like-for-like basis. In a normal 2018 cohort, roughly 25–30% of seed-stage startups reached Series A within 24 months. For the 2022 cohort, only about 17% did so. More frequent bridge rounds extend the test without guaranteeing graduation.[6]

2018 cohort

25–30%

2022 cohort

~17%

The decline measures graduation within the same 24-month window, not eventual graduation.

Source: [6]

The operating sequence has become slower and less forgiving: raise, extend runway, prove substantially more, survive a longer selection window and face an uncertain next round.

Graduation to the next round has become contingent and less predictable.

Rising valuations increasingly reflect selection

A smaller group of companies is raising at higher valuations. Carta reported a $24 million median seed post-money valuation and a $78.7 million median Series A post-money valuation in Q4 2025. In Q1 2026, Series B and Series C primary pre-money valuations were 17.2% and 12.5% higher year-on-year, respectively. These valuations describe a stronger surviving sample created by a narrower financing gate.[7]

A simple 100-company cohort illustrates the selection effect. In an easy market, perhaps 50 Series A companies reach Series B—a mix of excellent, average and weak businesses. In a difficult market, perhaps 15 succeed, concentrated among those with the strongest growth, margins, customers and investor support. The other 85 disappear from the valuation dataset as they cut costs, extend runway, seek bridges, sell or shut down. The median Series B valuation therefore reflects only the small group that cleared the gate.

A high median Series B valuation measures the strength of successful raisers and says little about the average Series A company. Market health depends on the percentage of Series A companies that reach Series B. A falling graduation rate turns higher headline valuations into evidence of stronger survivors passing through a narrower gate.

Selection weakens the median valuation as a measure of market breadth by removing most of the original sample.

Mortality is a lagging signal

Venture contractions reach bankruptcy with a delay. Startups first consume capital raised in the prior cycle, separating deteriorating funding conditions from visible shutdowns by months or years.

CB Insights' analysis of 431 VC-backed shutdowns found that the median company failed 22 months after its last financing. More than half failed within two years, while nearly a quarter survived more than three years without raising before eventually shutting down. Capital raised during the prior cycle can therefore conceal deterioration for years after funding conditions tighten.[8]

Failure unfolds as a process: funding difficulty, reduced hiring, weaker commercial activity, retrenchment, a bridge or runway extension, inability to raise and shutdown.

Cash exhaustion marks the terminal symptom. CB Insights found that 70% of the analysed companies eventually ran out of capital; upstream weaknesses included poor product-market fit (43%), bad timing or macro conditions (29%) and unsustainable unit economics (19%). Easy capital postpones recognition of these weaknesses, while scarce capital exposes them. The funding contraction is accelerating the discovery of business models that were already structurally weak.[9]

The delayed-mortality wave is still working through the system. SVB estimates that 2,345 VC-backed companies are on pace to fail in 2026—the highest level in recent history—with more than one-third founded during the zero-rate era. Many companies will survive, become profitable, bootstrap, merge or sell. A large cohort is still absorbing the consequences of the last cycle. Elevated mortality alongside rising aggregate funding confirms the decoupling of headline dollars from ecosystem health.[10]

22 monthsMedian time from last financing to shutdown

>50%Failed within two years of the last raise

~25%Survived more than three years without another raise

2,345VC-backed companies SVB estimates are on pace to fail in 2026

Source: [8] [10]

Fundraising concentration reinforces company-level concentration

The pattern extends from startups to funds. The number of new US venture funds fell 46% in 2024 and 68% between 2021 and 2024. Just nine firms accounted for nearly half of the capital raised by US venture funds in 2024. In 2025, vehicles with at least $100 million in commitments captured 57% of all capital raised by new funds on Carta, up from 31% eight years earlier.[11]

−68%New US venture funds, 2021–2024

9 firmsNearly half of US VC fund capital raised in 2024

57%Share of 2025 new-fund capital captured by vehicles ≥$100m

31%Comparable share eight years earlier

Source: [11]

The mechanism cascades. LPs become more selective. Fewer GPs raise funds. Surviving GPs protect reserves and concentrate capital. New investment declines. Follow-on hurdles rise. Weaker companies lose access to financing.

Capital is concentrating at both ends simultaneously: LP capital into fewer managers and GP capital into fewer companies, reinforcing venture's existing power-law structure. Historically, a small number of companies generated most gains after investment. Today, capital is concentrating before those outcomes are known. The industry is pre-committing to perceived winners, increasing the cost of selection error.

Europe and India confirm the regional concentration pattern. European VC investment was almost unchanged between Q1 and Q2 2026—$26.0 billion versus $25.6 billion—while deal count fell from 2,433 to 1,636. Investors deployed almost the same amount of capital across roughly one-third fewer transactions. India's technology startups raised $10.5 billion in 2025, 17% below 2024, while India remained the world's third-largest funded technology ecosystem.[12][13]

What this means in practice

Five things now define the market simultaneously: capital abundance at the very top; capital scarcity through the ordinary financing funnel; high prices for the survivors who clear an increasingly narrow gate; longer survival tests between rounds; and delayed mortality, since companies financed during the boom can operate for years before the new environment becomes visible in their numbers.

The hardest position to occupy is the middle, companies with respectable technology, reasonable growth and credible markets whose business models still require a venture round every 18 to 24 months. Those businesses were easy to finance when capital was abundant. They are much harder to finance when investors can concentrate around fewer perceived winners.

The scarce asset in VC today is continued access to capital.

Restricted access changes behaviour throughout the system.

Founders should manage runway as strategic optionality, build financing alternatives early and treat each new round as a structural risk within the operating plan.

Venture investors should assess reserve capacity alongside the initial cheque. The ability to fund a portfolio company through a prolonged drought increasingly shapes survival and the quality of the eventual outcome.

LPs should treat manager selection as the primary lever, since capital is clustering around funds perceived to have credible access to the small number of companies absorbing a disproportionate share of dollars.

Reading the market from here

Headline funding totals increasingly measure the financing of a few exceptional AI companies. Their growing share of US investment weakens the aggregate as an indicator of conditions facing the median startup.[14]

Five indicators diagnose the breadth and durability of the market:

1. What share of seed companies reach Series A, and how long does that transition take?
2. What proportion of rounds at each stage are bridges?
3. How concentrated is capital among the largest deals?
4. How many funds are successfully closing, and how much reserve capital sits behind existing portfolios?
5. How many companies have gone two or more years without financing?

The best single measure of venture-market health is the proportion of the ecosystem with credible access to another institutional round.

The defining feature of this cycle is that capital returned without restoring the system that once distributed it broadly.

For startups, aggregate capital recovery coexists with restricted access.

Founders should plan for longer fundraising cycles, higher evidence thresholds and a greater probability of delay or failure in the next round. Runway, capital efficiency and financing optionality now matter as much as growth.

The strategic objective is durable financeability: reaching the point at which capital competes for the company. The underlying market is narrower, more selective and more concentrated despite the recovery in headline funding.

References

1. [1]KPMG, 'Venture Pulse Q4 2025,' 24 Feb 2026. Source; KPMG, 'Venture Pulse Q2 2026,' 11 Aug 2026. Source
2. [2]KPMG, 'Venture Pulse Q4 2025,' 24 Feb 2026. Source; KPMG, 'Global VC investment reaches US$560.4 billion at mid-year,' 11 Aug 2026. Source
3. [3]PitchBook-NVCA, 'Q2 2026 Venture Monitor,' Jul 2026. Source; KPMG, 'Venture Pulse Q2 2026.' Source
4. [4]Carta, 'State of Private Markets: Q1 2026,' 29 May 2026. Source; PitchBook-NVCA, 'Q2 2026 Venture Monitor.' Source
5. [5]Carta, 'With fewer deals and fewer new funds, VC dollars are growing more concentrated,' 18 Feb 2025. Source; Carta, 'Series A Founders Should Plan to Make Capital Last 1000 Days,' 30 May 2025. Source
6. [6]Carta, 'Graduation rate from seed to Series A,' 5 Feb 2025. Source
7. [7]Carta, 'At early stages of VC, rising round sizes and record-breaking valuations,' 5 Mar 2026. Source; Carta, 'State of Private Markets: Q1 2026,' 29 May 2026. Source
8. [8]CB Insights, 'Why Startups Fail: Top 9 Reasons,' 5 Mar 2026. Source
9. [9]CB Insights, 'Why Startups Fail: Top 9 Reasons,' 5 Mar 2026. Source
10. [10]Silicon Valley Bank, 'State of the Markets H2 2026.' Source
11. [11]Carta, 'With fewer deals and fewer new funds, VC dollars are growing more concentrated,' 18 Feb 2025. Source; Carta, 'VC Fund Performance: Q1 2026,' 4 Jun 2026. Source
12. [12]KPMG, 'Europe: Q2 2026 Venture Pulse Report,' Aug 2026. Source
13. [13]Tracxn, 'India Tech Annual Funding Report 2025,' 26 Dec 2025. Source
14. [14]PitchBook-NVCA, 'Q2 2026 Venture Monitor.' Source